PGx Reporter (@PGxReporter) profile picture

GenomeWeb premium newsletter covering pharmacogenomics, personalized medicine, and companion diagnostics, including regulatory issues, payor trends, and more.

New York, NY
Joined November 2009
At AMP Corporate Event, BioFire Dx, Cepheid Presentations Offer Early Look at MDx Pipelines http://t.co/G64G9tanmR
1
1
Agilent's Q4 2014 Revenues Up 5 Percent http://t.co/DGjokaKiQR
1
Biocept Launches Blood-based Lung Cancer Dx to Guide Therapy in Patients Lacking Tissue Biopsy http://t.co/Ip27seTQMC
1
Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases http://t.co/ejJxQVBUuA
1
Gilotrif Survival Data for Del19 and L858R Patients has Implications for Treatment, Research http://t.co/2VAgY8Dza0
Note to Readers http://t.co/fk9iKAc9n1
People in the News: Nancy Cox, Matthew Ellis, John Bishop http://t.co/twzEiikKu2
Following Republican Election Gain, Detractors of FDA Lab Test Regulation Seize Chance for Support http://t.co/nzXlSzSL5M
Report Finds More Personalized Rx on the Market, but Field Lacks 'Integrator' http://t.co/jvlhCzbsra
Quest Launches Expanded Breast Cancer Risk Testing Service http://t.co/girMAUOKL8
Myriad Projects Stronger Revenue Growth in Second Half of FY2015 Driven by CDx, Prolaris http://t.co/6IXYG4B7uc
People in the News: Jeffrey Rona, Mark Colonnese http://t.co/SLonU4BKPy
Drawing Lessons from US Gene Patent Cases, Canadian Hospital Focuses on Enabling NGS Testing http://t.co/s5DCCo4vS8
Study IDs New Loci, Explains 5 Percent of Variation in Cholesterol-Lowering Effects of Statins http://t.co/4MLwBMHDYh
After Health Canada Approval, Spartan Plans to Launch Point-of-Care CYP2C19 Dx via Pharmacy Pilots http://t.co/Y1j0XuL5nu
Genome British Columbia Backs Regional Project to Study Benefits of Pharmacist-guided PGx Testing http://t.co/3pvjLoeHeQ
Arno's Onapristone Program Advancing in Castration-resistant Prostate Cancer, Gynecologic Tumors http://t.co/X00DIBm6tf
People in the News: Luis Gutierrez, Mara Aspinall, Greg Lucier, Valerie Palmieri http://t.co/yjQcva96R8
NanoString Study Shows Prosigna Can Assess Breast Cancer Patients' Risk of Late, Distant Recurrence http://t.co/l2W1UkSfke
Pharmacist Group Sees Value in Offering Assurex PGx Tests for Mental Health, Pain Rx Personalization http://t.co/6xmdr3GkgB